Literature DB >> 18222127

Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity.

Kjerstin Larsson1, Lars Lööf, Anders Rönnblom, Karin Nordin.   

Abstract

OBJECTIVE: Health-related quality of life (HRQoL) for patients with ulcerative colitis (UC) or Crohn's disease (CD) is influenced by symptoms and treatments. Periods with increased disease activity are specifically trying, but the knowledge of how patients manage this is sparse. The aim of this cross-sectional study was to examine (1) HRQoL for patients with UC or CD, (2) how patients cope with increased disease activity, and (3) if coping is associated with HRQoL.
METHODS: A postal questionnaire was sent to patients with UC and CD who attended the gastroenterology and surgery department at a Swedish university hospital. Coping, HRQoL, and emotional well-being were assessed by Jalowiec Coping Scale, Short Form-36 Health survey, Short Health Scale, and the Hospital Anxiety and Depression Scale.
RESULTS: Patients with increased disease activity reported impaired HRQoL and emotional distress. This was more prevalent among patients with CD, as compared to patients with UC. Optimistic, self-reliant and confrontive coping strategies were most frequently used to manage stressors, with no differences found between patients in exacerbation or remission or between patients with UC or CD.
CONCLUSION: Impaired HRQoL and emotional distress is prevalent among patients with exacerbation in UC and CD. Thus, a complete evaluation of psychosocial status and management of psychosocial distress should be included in the clinical treatment of the patient. Patients use a variety of coping strategies in an effort to manage increased disease activity. However, these results did not support any associations between coping and HRQoL.

Entities:  

Mesh:

Year:  2008        PMID: 18222127     DOI: 10.1016/j.jpsychores.2007.10.007

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  28 in total

1.  Optimizing management of Crohn's disease within a project management framework: results of a pilot study.

Authors:  Laurie Keefer; Bethany Doerfler; Caroline Artz
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

Review 2.  Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

Authors:  Branislav R Filipovic; Branka F Filipovic
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

3.  Differing Relationship of Psycho-Social Variables with Active Ulcerative Colitis or Crohn's Disease.

Authors:  Orly Sarid; Vered Slonim-Nevo; Doron Schwartz; Michael Friger; Ruslan Sergienko; Avihu Pereg; Hillel Vardi; Elena Chernin; Terri Singer; Dan Greenberg; Shmuel Odes
Journal:  Int J Behav Med       Date:  2018-06

4.  Symptom clusters in adults with inflammatory bowel disease.

Authors:  Samantha Conley; Deborah D Proctor; Sangchoon Jeon; Robert S Sandler; Nancy S Redeker
Journal:  Res Nurs Health       Date:  2017-08-17       Impact factor: 2.228

5.  Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease.

Authors:  Thiago H Freitas; Elias Andreoulakis; Gilberto S Alves; Hesley L L Miranda; Lúcia L B C Braga; Thomas Hyphantis; André F Carvalho
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

6.  Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis.

Authors:  Bruce D Naliboff; Sharon E Kim; Roger Bolus; Charles N Bernstein; Emeran A Mayer; Lin Chang
Journal:  Am J Gastroenterol       Date:  2011-11-15       Impact factor: 10.864

7.  Disease-specific knowledge, coping, and adherence in patients with inflammatory bowel disease.

Authors:  Anilga Moradkhani; Lauren Kerwin; Sharon Dudley-Brown; James H Tabibian
Journal:  Dig Dis Sci       Date:  2011-05-03       Impact factor: 3.199

8.  The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure.

Authors:  Laurie Keefer; Jennifer L Kiebles; Tiffany H Taft
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

9.  Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease.

Authors:  Jennifer L Kiebles; Bethany Doerfler; Laurie Keefer
Journal:  Inflamm Bowel Dis       Date:  2010-10       Impact factor: 5.325

10.  Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life.

Authors:  Alejandra H Faust; Leslie F Halpern; Sharon Danoff-Burg; Raymond K Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.